# Live Oak Health Sciences Fund (LOGSX): Mutual Fund Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/logsx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: — · Asset class: Equity - Strategy: Actively Managed · Inception: 2001-06-29 This fund primarily invests in the common stock of companies operating within the healthcare, medical, or life sciences fields. These businesses are typically involved in the research, development, manufacturing, or distribution of related products and services. Under normal market conditions, a minimum of 80% of the fund's net assets will be dedicated to equity investments in such health science enterprises. While the portfolio's main emphasis is on U.S. company common stocks, it retains the option to a lesser degree to include equity REITs, foreign company shares, and American Depositary... ## Key Facts | Metric | Value | |---|---| | Price | $27.49 | | Expense Ratio | 1.04% | | Assets Under Management | $62.1M | | NAV | $27.49 (2026-10-30 close) | | Holdings Count | — | | Distribution Yield (TTM) | 1.77% | | Annual Distribution (TTM) | $0.49 /share | | Distribution Frequency | Annual | | 52-Week Range | $22.39 – $27.50 | | Beta | 0.42 | ## Latest Distribution - Amount: $0.4879 /share - Ex-date: 2025-12-29 - Pay date: 2025-12-29 ## Frequently Asked Questions ### What does LOGSX invest in? This fund primarily invests in the common stock of companies operating within the healthcare, medical, or life sciences fields. These businesses are typically involved in the research, development, manufacturing, or distribution of related products and services. Under normal market conditions, a minimum of 80% of the fund's net assets will be dedicated to equity investments in such health science enterprises. While the portfolio's main emphasis is on U.S. company common stocks, it retains the option to a lesser degree to include equity REITs, foreign company shares, and American Depositary Receipts, provided these investments meet the fund's established criteria. ### What is the expense ratio of LOGSX? Live Oak Health Sciences Fund (LOGSX) charges an expense ratio of 1.04%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is LOGSX? Live Oak Health Sciences Fund (LOGSX) manages $62.1M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is LOGSX actively managed or an index fund? LOGSX is actively managed: the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (LOGSX's is 1.04%) in exchange for the discretion to over- or under-weight positions. ### When was LOGSX launched? Live Oak Health Sciences Fund (LOGSX) launched in June 2001 and is managed by the fund issuer. ### How has LOGSX performed? LOGSX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does LOGSX pay a dividend? Live Oak Health Sciences Fund (LOGSX) currently distributes little or no income. Trailing-twelve-month yield is 1.77%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does LOGSX pay dividends? Live Oak Health Sciences Fund pays dividends Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is LOGSX's dividend yield? LOGSX's trailing-twelve-month yield is 1.77%, calculated from the sum of dividends over the past year divided by the current price. ### When is LOGSX's next ex-dividend date? The most recently announced ex-dividend date for LOGSX was 2025-12-29. The next ex-date typically follows Annual; once announced it appears at the top of the dividend history table on this page. ### How much will LOGSX's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 1.04% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does LOGSX charge its expense ratio? The expense ratio is deducted in tiny daily slices from LOGSX's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does LOGSX cost more than a fund like VOO? LOGSX is actively managed (current expense ratio 1.04%). Active funds charge more than passive index trackers in exchange for the manager's discretion to over- or under-weight positions. The Cost Verdict card above tells you whether LOGSX's fee is competitive for the active-management cohort. ### Are there cheaper alternatives to LOGSX? The Lower-Fee Alternatives card above lists mutual funds following the same investment strategy as LOGSX (1.04%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/logsx - Distribution history: https://www.dividenddata.com/funds/logsx/dividend - Holdings & diversification: https://www.dividenddata.com/funds/logsx/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/logsx/expenses - Peer comparison: https://www.dividenddata.com/funds/logsx/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.